Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling.
about
The immune pathogenesis of scleroderma: context is everythingSTAT6 and PARP Family Members in the Development of T Cell-dependent Allergic InflammationNew insights into T cells and their signature cytokines in atopic dermatitisWhy we scratch an itch: the molecules, cells and circuits of itchEpidermal RAF prevents allergic skin diseaseIL-13 from intraepithelial lymphocytes regulates tissue homeostasis and protects against carcinogenesis in the skinTRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis.Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cellsAsthma-like airway inflammation and responses in a rat model of atopic dermatitis induced by neonatal capsaicin treatment.Mast cells in atopic dermatitisWhat targeting eosinophils has taught us about their role in diseases.Epicutaneous exposure to staphylococcal superantigen enterotoxin B enhances allergic lung inflammation via an IL-17A dependent mechanism.The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma.IL-13Rα2 has a protective role in a mouse model of cutaneous inflammationProinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.Semaphorin 3A controls allergic and inflammatory responses in experimental allergic conjunctivitis.Oleanolic acid controls allergic and inflammatory responses in experimental allergic conjunctivitisTh2 Cytokines and Atopic Dermatitis.IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin.Tonggyu-tang, a traditional Korean medicine, suppresses pro-inflammatory cytokine production through inhibition of MAPK and NF-κB activation in human mast cells and keratinocytes.Topical application of herbal mixture extract inhibits ovalbumin- or 2,4-dinitrochlorobenzene-induced atopic dermatitisIL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing.Coexistence of 2282del4 FLG gene mutation and IL-18 -137G/C gene polymorphism enhances the risk of atopic dermatitis.Chemokine-like factor 1 (CLFK1) is over-expressed in patients with atopic dermatitis.Atopic dermatitis: the role of Langerhans cells in disease pathogenesis.IgE, mast cells, and eosinophils in atopic dermatitis.The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis.Peripheral mechanisms of itch.Cytokines and the skin barrier.Molecular biology of atopic dermatitis.Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?Epigallocatechin-3-O-gallate inhibits the production of thymic stromal lymphopoietin by the blockade of caspase-1/NF-κB pathway in mast cells.Targeting key proximal drivers of type 2 inflammation in disease.PARP14 limits severity of allergic skin disease.The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.Preclinical and human surrogate models of itch.The role of ILC2 in hookworm infection.Inflammatory and Noninflammatory Itch: Implications in Pathophysiology-Directed Treatments.Association of polymorphisms in genes encoding IL-4, IL-13 and their receptors with atopic dermatitis in a Korean population.Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch.
P2860
Q24633658-99AF89E6-D387-46E7-BDFB-92AA8F7C94EAQ26738332-DA37DD42-0C7A-4904-96B4-B13B2492AD0CQ26801199-61C1AAF5-D54A-4352-98F5-CA0A81669C8DQ26865093-F94F3DA5-8D99-45F7-B0B9-184CD59DC209Q28829587-265F65DC-844B-4A9C-96B7-572DDE927E48Q28831392-D2799CB0-13A4-4E05-9CB0-A9FB5C8C1BE9Q30587902-73E4081A-F3E4-4E70-88F6-180D165AFED6Q30612542-4400FAED-CADA-41E5-B604-7B7368057511Q33719258-687A5075-F579-4683-9283-649E4BD205BCQ33731849-6A59B04D-2A59-480D-8BB6-525828E4D8F8Q33987218-CBB105DD-F6B5-4D37-BE53-A729FB8653D5Q34357756-A1A935A1-DBE6-4651-9072-BF5D1E9E917AQ34556081-D85B8AC9-8F0C-4A9F-A2FD-F1ED2FA36754Q34610797-88260011-E621-45E4-AFB3-9E9FDBD62AE3Q34674982-7057026A-A2AB-47A0-B798-7CFCC41CECD2Q35075328-E4C94700-FF20-4DAA-9C36-B1921C893014Q35139177-1A7471B9-967C-4630-AB81-85A0074DD99DQ35294155-EEC27C37-383F-4A07-9BE4-E40864E2E35EQ36102435-D1FE19D7-24B7-43A3-B8A7-A074C63250A7Q36328682-8131D34A-1347-4A1F-B58B-153CC3E0E2AFQ36477969-94EE7C58-3614-463B-B892-AACF44AFF629Q36514695-E6BDEE80-C013-45A3-B8E4-9C631A92CCACQ36690506-5A7A7E4D-8D42-4B01-8DC9-38175D7E0742Q37121463-4AAF9D9F-165A-4CE3-9FE1-F44244A77937Q37721153-B57839B9-CBF6-496A-B6B9-47D8CE05C7D4Q37830373-4934EB80-AE5C-47FD-8A6E-4B9CFB4F2D06Q37889392-1B733372-2678-40BC-ACA7-B047E1246DD1Q37998859-6A4D26C5-7D80-4672-B9E7-A3B6C14A473BQ38093338-A94C4B52-632F-4F64-9751-1DA4DCE03C34Q38203185-B17755BF-6318-48D9-AA44-9482C24D0245Q38452688-2CEA0460-167D-45AF-8F1A-E1C6A8A23A85Q38471521-17EFF1FC-D941-4F21-997B-3E21C0CBF2FDQ38608260-6A9482D6-C847-496B-9EFF-71B6CF81A9D5Q38707649-DC2205E7-3EED-43D5-BE97-828C6A62BECAQ38733182-22645CD1-91D9-42D7-B28E-956F26B554ABQ38837892-B6A282B5-B913-442D-B85D-67226F93840FQ39215742-96D46555-C2AA-4F0C-91A6-1337330EFF1AQ39429573-3A5632EE-3BE3-4FC1-A100-AE98C62745B6Q39708079-E89974D7-4F2A-4665-AED2-4A60545F81E5Q40058426-84E58D01-E91D-4B36-882E-BA9C2F664B3D
P2860
Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Transgenic expression of inter ...... ermatitis and skin remodeling.
@en
Transgenic expression of inter ...... ermatitis and skin remodeling.
@nl
type
label
Transgenic expression of inter ...... ermatitis and skin remodeling.
@en
Transgenic expression of inter ...... ermatitis and skin remodeling.
@nl
prefLabel
Transgenic expression of inter ...... ermatitis and skin remodeling.
@en
Transgenic expression of inter ...... ermatitis and skin remodeling.
@nl
P2093
P2860
P356
P1476
Transgenic expression of inter ...... ermatitis and skin remodeling.
@en
P2093
Adam B Glick
John T Schroeder
P2860
P2888
P304
P356
10.1038/JID.2008.295
P407
P577
2008-10-02T00:00:00Z